β2-adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells

International Archives of Allergy and Immunology

Volumn 152, Issue 4, 2010, Pages 353-361

  Futamura, Kyoko ^a,c   Orihara, Kanami ^a   Hashimoto, Noriko ^a   Morita, Hideaki ^a,b   Fukuda, Shuhei ^a   Sagara, Hironori ^d   Matsumoto, Kenji ^a   Tomita, Yasushi ^c   Saito, Hirohisa ^a   Matsuda, Akio ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

2 Adrenoceptor agonists; Asthma; Corticosteroid; Lung tissue cells; Thymic stromal lymphopoietin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; FLUTICASONE; FORMOTEROL; FORSKOLIN; INTERLEUKIN 4; SALBUTAMOL; SALMETEROL; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; ANDROSTANE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CYCLIC AMP; CYTOKINE;

ALLERGIC DISEASE; ARTICLE; BRONCHUS MUCOSA; CELL STIMULATION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION; ASTHMA; BIOSYNTHESIS; CELL CULTURE; DRUG COMBINATION; FIBROBLAST; GENETICS; LUNG; METABOLISM; PATHOLOGY; RESPIRATORY TRACT MUCOSA;

ADRENERGIC BETA-AGONISTS; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; DRUG THERAPY, COMBINATION; FIBROBLASTS; HUMANS; INTERLEUKIN-4; LUNG; MYOCYTES, SMOOTH MUSCLE; RESPIRATORY MUCOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954512739     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288288     Document Type: Article

References (20)

1. Ellis C, Luger T: International Consensus Conference on Atopic Dermatitis II (ICCAD II): Chairman's introduction and overview. Br J Dermatol 2003; 148: 1-2.
2. Whrich B, Cozzio A, Roll A, Senti G, Kdig T, Schmid-Grendelmeier P: Atopic eczema: genetics or environment? Ann Agric Environ Med 2007; 14: 195-201.
3. Avgerinou G, Goules AV, Stavropoulos PG, Katsambas AD: Atopic dermatitis: new immunologic aspects. Int J Dermatol 2008; 47: 219-224.
4. Kurukulaaratchy RJ, Matthews S, Arshad SH: Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease. Allergy 2005; 60: 1280-1286.
5. Scadding GK: Further marches: allergic and non-allergic. Clin Exp Allergy 2007; 37: 485-487.
6. Hahn EL, Bacharier LB: The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am 2005; 25: 231-246.
7. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A, Klopp N, Vogelberg C, Weiland SK, McLean WH, von Mutius E, Irvine AD, Kabesch M: Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008; 121: 1203-1209.
8. Illi S, von Mutius E, Lau S, Nickel R, Grer C, Niggemann B, Wahn U, Multicenter Allergy Study Group: The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
9. Nicholson JF, Pesce MA: Reference ranges for laboratory tests and procedures; in Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics. Pennsylvania, Saunders, 2004, pp 2396-2426.
10. Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, Carlsen KH, van Cauwenberge P, Darsow U, Fokkens WJ, Haahtela T, van Hoecke H, Jessberger B, Kowalski ML, Kopp T, Lahoz CN, Lodrup Carlsen KC, Papadopoulos NG, Ring J, Schmid-Grendelmeier P, Vignola AM, Wrl S, Zuberbier T: Standard skin prick testing and sensitization to inhalant allergens across Europe-a survey from the GALEN network. Allergy 2005; 60: 1287-1300.
11. Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J: Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1,550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol 2004; 150: 96-102.
12. Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group: Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008; 63: 742-750.
13. Yuksel H, Dinc G, Sakar A, Yilmaz O, Yorgancioglu A, Celik P, Ozcan C: Prevalence and comorbidity of allergic eczema, rhinitis, and asthma in a city in western Turkey. J Investig Allergol Clin Immunol 2008; 18: 31-35.
14. Novembre E, Cianferoni A, Lombardi E, Bernardini R, Pucci N, Vierucci A: Natural history of 'intrinsic' atopic dermatitis. Allergy 2001; 56: 452-453.
15. Flohr C, Johansson SG, Wahlgren CF, Williams H: How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114: 150-158.
16. Williams H, Flohr C: How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006; 118: 209-213.
17. Flohr C, Weiland SK, Weinmayr G, Bjkst B, Brk L, Brunekreef B, Bhele G, Clausen M, Cookson WO, von Mutius E, Strachan DP, Williams HC, ISAAC Phase Two Study Group. The role of atopic sensitization in flexural eczema: findings from the International Study of Asthma and Allergies in Childhood Phase Two. J Allergy Clin Immunol 2008; 121: 141-147.
18. Wahn U, Warner J, Simons FE, de Benedictis FM, Diepgen TL, Naspitz CK, de Longueville M, Bauchau V; EPAAC Study Group: IgE antibody responses in young children with atopic dermatitis. Pediatr Allergy Immunol 2008; 19: 332-336.
19. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Abramson MJ, Hill DJ, Dharmage SC: Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol 2008; 121: 1190-1195.
20. Novak N: New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 2009; 64: 265-275.